DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Droloxifene
Droloxifene
Abnormal Uterine Bleeding, 108, 113 Acupuncture, 159-160
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) Patent Application Publication (10) Pub. No.: US 2001/0047033 A1 Taylor Et Al
Blockade of the Stimulatory Effect of Estrogens, OH-Tamoxifen, OH
Design and Synthesis of Selective Estrogen Receptor Β Agonists and Their Hp Armacology K
Pure Oestrogen Antagonists for the Treatment of Advanced Breast Cancer
Stembook 2018.Pdf
Identification of Novel Regulatory Genes in Acetaminophen
OSTEOPOROSIS New Data Enhance Our Understanding of the Effects of Some Contraceptives and Key Serms on the Skeletal Health of Users
Diethylstilbestrol and Media Coverage of the "Morning After" Pill
Gungor Serms Manuscript Revised
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Effects of Hormone Therapy on Blood Pressure
Customs Tariff - Schedule
Inhibition of Angiogenesis by Antiestrogens1
(12) United States Patent (10) Patent No.: US 7,829,112 B2 Ron Et Al
Estrogen Receptor/ERR
= O D Z Dose of Neurokinin B Infusion O (Nmol/Kg/H)
Top View
The Pharmacologic Modulation of Estrogen Receptor Activity
The Estrogenic and Antiestrogenic Activities of Droloxifene in Human Breast Cancers
Conjugated Estrogens)
The Discovery and Development of Selective Estrogen Receptor Modulators (Serms) for Clinical Practice
Harmonized Tariff Schedule of the United States (2006) (Rev
Breast Cancer Is Predominantly a Disease of West- Contraception Or for Treatment of Menopausal Ern, Industrialized Countries
Treatment of Hot Flushes, Vasomotor Symptoms, and Night Sweats with Sex Steroid Precursors in Combination with Selective Estrogen Receptor Modulators
Design, Synthesis and Biological Screening of Focused Libraries of New Antiestrogens
Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects
Combinations of Droloxifene with Progestins for the Treatment of Osteoporosis
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2009/0060982 A1 Ron Et Al
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) Patent Application Publication (10) Pub. No.: US 2007/0196433 A1 Ron Et Al
Endocrine Manipulation in Advanced Breast Cancer: Recent Advances with SERM Therapies
Droloxifene Citrate LKT Laboratories, Inc
Gungor Serms Final Accepted
Effect of Raloxifene on IGF-I and IGFBP-3 in Postmenopausal Women with Breast Cancer